Tim Moore's GNPX trades
- The latest GNPX trade was a purchase on Feb 5, 2026, when GNPX closed at $43.12. It closed at $2.33 on Nov 3, 2026 (-95%).
- None of the 4 GNPX purchases we can price are higher today. The median one is -96%, against +12% for the S&P 500 over the same holding periods.
Price changes use the closing price on each trade date, not the price actually paid, and ignore dividends. Filings report amounts only as ranges, so these figures show direction, not anyone's actual profit.
Tim Moore reported 4 GNPX transactions in 4 filings with the House Clerk for 2025–2026: 4 purchases and 0 sales of Genprex, Inc. - Common Stock, with trade dates from Oct 29, 2025 to Feb 5, 2026. The median gap between trade date and filing date is 18 days, and every trade was reported within 45 days.
- 4
- 4 / 0
- $18K – $95K
- 2026-02-20
GNPX transactions reported by Tim Moore
| Type | Owner | ||||
|---|---|---|---|---|---|
Genprex, Inc. - Common Stock GNPX | Purchase | Self | $1,001 - $15,000 | 2026-02-20 #20034034 | |
Genprex, Inc. - Common Stock GNPX | Purchase | Self | $1,001 - $15,000 | 2026-01-07 #20033746 | |
Genprex, Inc. - Common Stock GNPX | Purchase | Self | $1,001 - $15,000 | 2025-12-02 #20033564 | |
Genprex, Inc. - Common Stock GNPX | Purchase | Self | $15,001 - $50,000 | 2025-11-12 #20033413 |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
How long disclosure took
Days from trade date to filing date for 4 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 2
- 16–30 days
- 2
- 31–45 days
- 0
- Over 45 days
- 0
- Median / longest
- 18d / 25d
What Tim Moore's GNPX filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- NVIDIA’s growth has a financing bill
Sales up about 18% on the prior quarter, receivables up about 55%, supply commitments at $279 billion. What NVIDIA’s financing bill means for the price you pay.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchMore tickers reported by Tim Moore
Tim Moore and GNPX: questions
Did Tim Moore buy or sell GNPX?
House Clerk filings for 2025 and 2026 show 4 purchases and 0 sales of Genprex, Inc. - Common Stock (GNPX) reported by Tim Moore, between 2025-10-29 and 2026-02-05. Reported owner: Self.
How much GNPX did Tim Moore trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $18K – $95K across 4 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last GNPX filing by Tim Moore?
The most recent filing that includes a GNPX trade was filed on 2026-02-20. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with Genprex, Inc. - Common Stock. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
Tim Moore GNPX disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included